Trial Profile
Prevention of osteoporosis in breast cancer survivors
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Dec 2023
Price :
$35
*
At a glance
- Drugs Risedronic acid (Primary) ; Calcium; Vitamin D analogues
- Indications Osteoporosis
- Focus Therapeutic Use
- 29 Aug 2023 Phase of the trial changed from phase 4 to not applicable.
- 15 Jan 2010 Actual patient number (249) added as reported by ClinicalTrials.gov.
- 20 Dec 2007 New trial record.